At Arbor Biotechnologies, we develop genetic medicines through the discovery of programmable DNA editors to enable functionally curative outcomes for patients. Founded by CRISPR pioneer Feng Zhang alongside David Walt, David Scott, and Winston Yan, we're building on our founde…